Immunosuppressive therapy maintenance in a kidney transplant recipient with SARS-CoV-2 pneumonia: A case report

43Citations
Citations of this article
184Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The role of systemic inflammation is proving crucial in determining unfavorable outcome in SARS-CoV-2–infected patients. Limited data are available regarding immunosuppression management in kidney transplant recipients (KTRs) with SARS-CoV-2 pneumonia. We report a case of a 32-year-old KTR who developed SARS-CoV-2 infection and fully recovered in 15 days while maintaining standard immunosuppressive therapy.

Cite

CITATION STYLE

APA

Bussalino, E., De Maria, A., Russo, R., & Paoletti, E. (2020). Immunosuppressive therapy maintenance in a kidney transplant recipient with SARS-CoV-2 pneumonia: A case report. American Journal of Transplantation, 20(7), 1922–1924. https://doi.org/10.1111/ajt.15920

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free